Nucleic acid delivery to mesenchymal stem cells: a review of nonviral methods and applications
Abstract Background Mesenchymal stem cells (MSCs) are multipotent stem cells that can be isolated and expanded from many tissues, and are being investigated for use in cell therapies. Though MSC therapies have demonstrated some success, none have been FDA approved for clinical use. MSCs lose stemnes...
Main Authors: | Andrew Hamann, Albert Nguyen, Angela K. Pannier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Journal of Biological Engineering |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13036-019-0140-0 |
Similar Items
-
Glucocorticoid Priming of Nonviral Gene Delivery to hMSCs Increases Transfection by Reducing Induced Stresses
by: Andrew Hamann, et al.
Published: (2020-09-01) -
High-throughput screening of clinically approved drugs that prime nonviral gene delivery to human Mesenchymal stem cells
by: Tyler Kozisek, et al.
Published: (2020-05-01) -
The role of surface chemistry-induced cell characteristics on nonviral gene delivery to mouse fibroblasts
by: Kasputis Tadas, et al.
Published: (2012-09-01) -
Mesenchymal Stem Cells Engineered by Nonviral Vectors: A Powerful Tool in Cancer Gene Therapy
by: Yuan Ding, et al.
Published: (2021-06-01) -
Comparison of promoter, DNA vector, and cationic carrier for efficient transfection of hMSCs from multiple donors and tissue sources
by: Tyler Kozisek, et al.
Published: (2021-12-01)